November 21, 2025

CorMedix Inc. (CRMD): A Biotech Stock with a Promising 95% Upside Potential

Investors seeking growth opportunities in the biotechnology sector may find CorMedix Inc. (NASDAQ: CRMD) a compelling consideration. As a U.S.-based healthcare innovator, CorMedix focuses on developing therapeutic products aimed at..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unpacking the 16.98% Potential Upside in the Diagnostics Sector

As the healthcare industry continues to evolve, Fulgent Genetics, Inc. (NASDAQ: FLGT) emerges as a noteworthy player in the diagnostics and research sector. Situated in the dynamic landscape of clinical..

AMN Healthcare Services Inc (AMN): Investor Outlook Highlights 35% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN), a key player in the medical care facilities industry, offers a wide array of technology-enabled healthcare workforce solutions. Based in Dallas, Texas, AMN has..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 25% Potential Upside with Robust Buy Ratings

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making waves in the biotechnology sector, drawing investor attention with its promising pipeline and significant market potential. With a market capitalization of $1.87 billion,..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Decoding the 180% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at a pivotal juncture within the biotechnology sector, capturing investor interest with its ambitious gene therapy programs aimed at tackling rare and severe diseases...

Anavex Life Sciences Corp. (AVXL) Investor Outlook: Exploring a 594% Potential Upside in the Biotechnology Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL), a promising player in the biotechnology sector, is making waves with its ambitious focus on treating complex neurodegenerative and neuropsychiatric disorders. Despite recent market..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a Massive 255% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is capturing investor attention with its promising therapeutic pipeline and a remarkable potential upside of 255.50%. As a biopharmaceutical company specializing in cell therapies for..

AxoGen, Inc. (AXGN) Stock Analysis: A 23.5% Revenue Growth Propels Positive Investor Outlook

AxoGen, Inc. (NASDAQ: AXGN) is capturing the attention of investors in the healthcare sector, particularly within the medical devices industry, where its innovative approaches to peripheral nerve regeneration are driving..

Semler Scientific, Inc. (SMLR) Stock Analysis: A Healthcare Gem with 255% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR) is capturing investor attention with its significant potential upside, as indicated by a robust analyst target price range. Despite recent challenges, including a notable dip..

Butterfly Network, Inc. (BFLY) Stock Analysis: Evaluating a Potential 68.82% Upside

Butterfly Network, Inc. (BFLY), a player in the healthcare sector specializing in medical devices, has been capturing investor attention with its innovative ultrasound imaging solutions. With a market cap of..

CeriBell, Inc. (CBLL) Stock Analysis: Unveiling an 81% Potential Upside

CeriBell, Inc. (CBLL) is making waves in the healthcare sector with its innovative approach to addressing neurological conditions. As a medical technology company, CeriBell is pioneering advancements with its revolutionary..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a 32.9% Potential Upside Amid Challenges

Community Health Systems, Inc. (CYH) operates at the heart of the U.S. healthcare sector, running a network of general acute care hospitals that provide a broad spectrum of medical services...

Valneva SE (VALN) Stock Analysis: Exploring a 36.62% Potential Upside in the Booming Biotech Sector

Valneva SE (VALN), a French biotechnology company, has rapidly emerged as a key player in the healthcare sector with its innovative approach to vaccines. Specializing in the development, manufacturing, and..

Altimmune, Inc. (ALT) Stock Analysis: Unveiling a 270% Potential Upside in Biotech

Altimmune, Inc. (NASDAQ: ALT) has captured the attention of investors with its compelling narrative and significant potential upside. As a clinical-stage biopharmaceutical company, Altimmune is primarily focused on developing innovative..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: High Growth Potential with a 96% Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands as a promising player in the biotechnology sector, catching the attention of investors with its high-growth potential and a substantial potential upside of 96.08%...

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring 33.73% Potential Upside in Biotech

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with a promising pipeline targeting chronic Hepatitis B virus (HBV). With a market capitalization..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Powerhouse with 75% Upside Potential

Immatics N.V. (NASDAQ: IMTX), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment. With a market capitalization of $1.23..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Biotechnology Innovator with a 199% Potential Upside

Cullinan Therapeutics, Inc. (CGEM) is capturing investor attention with its promising potential upside of 199.44%, as suggested by the average target price set by analysts. As a clinical-stage biopharmaceutical company,..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth with a 90.17 Forward P/E

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, is an intriguing prospect for investors, particularly due to its focus on innovative eye care..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking the 171.81% Upside Potential

Investors seeking opportunities in the biotechnology space may want to keep an eye on REGENXBIO Inc. (NASDAQ: RGNX), a company that is making waves with its innovative gene therapy solutions...

Search

Funds

November 21, 2025

Search

Funds

November 21, 2025

FTSE 100

Funds